Healthcare / Medical Care FacilitiesBSE
$1364.80
+7.90 (+0.57%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.0B · quality 59.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
57/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$138.4B
P/E
49.8x
↑EV/EBITDA
25.1x
↑ROE
16.9%
↑Gross Margin
86.7%
↑Debt/Equity
0.54
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+13.6%
FCF CAGR
+2.7%
FCF margin
11.9%
FCF / Net income
0.73x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $17.03B · net income $2.78B · FCF $2.03B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $17.03B | $17.03B | $15.16B | $12.86B | $11.61B |
| Net Income | $2.78B | $2.78B | $2.43B | $2.17B | $2.11B |
| EBITDA | $5.86B | $5.86B | $5.41B | $4.66B | $4.27B |
| EPS | 27.41 | 27.41 | 23.84 | 21.38 | 20.89 |
| Gross Margin | 86.7% | 86.7% | 87.1% | 87.1% | 86.4% |
| Operating Margin | 23.1% | 23.1% | 23.2% | 25.2% | 27.1% |
| Net Margin | 16.3% | 16.3% | 16.1% | 16.9% | 18.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.54 | 0.54 | 0.52 | 0.61 | 0.54 |
| Current Ratio | 3.59 | 3.59 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.03B | $2.03B | $2.50B | $-321.8M | $1.87B |
| Returns | |||||
| ROE | 16.9% | 16.9% | 16.6% | 17.2% | 19.9% |
| Valuation | |||||
| P/E | 49.77 | 49.77 | 59.09 | 63.16 | 35.68 |
| EV/EBITDA | 25.09 | 25.09 | 27.97 | 31.11 | 18.93 |
| P/B | 8.41 | 8.41 | 9.80 | 10.91 | 7.10 |
| Growth & Yield | |||||
| Revenue Growth | 12.4% | 12.4% | 17.9% | 10.8% | — |
| EPS Growth | 15.0% | 15.0% | 11.5% | 2.3% | — |
| Dividend Yield | 0.3% | 0.3% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
64.1%
EPS terminal req.
$121.10
Spread vs growth
-49.1%
5Y implied EPS CAGR
39.8%
EPS terminal req.
$146.53
Spread vs growth
-24.9%
10Y implied EPS CAGR
24.0%
EPS terminal req.
$236.00
Spread vs growth
-9.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+2.5%
Start / end P/E
56.8x → 50.5x
EPS bridge
23.84 → 27.41
Residual
-1.7%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.